Search

Subject Ovarian Neoplasms

3. Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer. Issue 4 (5th January 2023)

Authors:
Andrikopoulou, Angeliki; Liontos, Michalis; Skafida, Efthymia; Koutsoukos, Konstantinos; Apostolidou, Kleoniki; Kaparelou, Maria; Rouvalis, Angeliki; Bletsa, Garyfallia; Dimopoulos, Meletios-Athanasios; Zagouri, Flora
Journal:
International journal of gynecological cancer
Issue:
Volume 33:Issue 4(2023)
Page Start:
571
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search